Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
Research Scientist, Cell Pharmacology - CVM Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 16, 2024
Research Scientist II San Diego USA Biomedical Research Pharma Research Research & Development Oct 01, 2024
Research Scientist - Lab Technician (Dual Posting) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 26, 2024
Research Informatics Product Growth Manager x3 (US or Switzerland) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development May 08, 2024
Renal Medical Lead Seoul South Korea International Innovative Medicines Research & Development Sep 01, 2024
Regulatory Affairs Medical Device Manager (Schaftenau, Austria) Schaftenau Austria Development Innovative Medicines Research & Development Sep 02, 2024
Regulatory Affairs Manager Kyiv Ukraine Development Innovative Medicines Research & Development May 10, 2024
Regulatory Affairs Manager New South Wales (NSW) Australia Development Innovative Medicines Research & Development Oct 06, 2024
Regulatory Affairs Manager Beijing (Beijing) China Development Innovative Medicines Research & Development Sep 01, 2024
Regulatory Affairs CMC Senior Manager Schaftenau Austria Development Innovative Medicines Research & Development Sep 02, 2024
Regulatory Affairs CMC Associate Director Schaftenau Austria Development Innovative Medicines Research & Development Sep 30, 2024
RA Specialist Croatia Croatia Development Innovative Medicines Research & Development Oct 18, 2024
RA Operational Excellence Junior Associate – MEA Dubai Utd.Arab Emir. Development Innovative Medicines Research & Development Oct 16, 2024
RA Manager, Procedural Documents London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 10, 2024
RA Manager INSURGENTES Mexico Development Innovative Medicines Research & Development Sep 03, 2024
RA Head India Mumbai (Head Office) India Development Sandoz Research & Development Oct 25, 2024
RA CMC Senior Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
RA CMC Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
RA CMC Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
RA CMC Associate Manager-II Hyderabad (Office) India Development Innovative Medicines Research & Development May 30, 2024
RA CMC Associate Manager-II Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
RA CMC Associate Manager - II Hyderabad (Office) India Development Innovative Medicines Research & Development Jun 19, 2024
Qualification Expert (m/f/d) Ivrea Italy International Innovative Medicines Research & Development Oct 24, 2024
QC Senior Scientist Ivrea Italy International Innovative Medicines Research & Development Oct 14, 2024
Project Team Coordinator (Medical) (m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Research & Development Oct 15, 2024
Product Manager - Research Informatics (Sample Shipping and Compliance) Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Sep 03, 2024
Principle Scientist, Molecular Imaging Expert Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Aug 18, 2024
Principal Scientist, Modeling & Simulation RLT Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 03, 2024
Principal Scientist II Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Oct 23, 2024
Principal Scientist 2 - Preclinical Safety Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Jul 22, 2024
Principal Scientist – Covalency & Exploratory Chemical Biology Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Aug 15, 2024
Principal Scientist - Pathology Telangana India Biomedical Research Pharma Research Research & Development Sep 03, 2024
Principal Scientist Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Apr 24, 2024
Principal Scientific Writer Hyderabad (Office) India Operations CTS Research & Development Sep 03, 2024
Principal RWE Research Analyst Hyderabad (Office) India Operations CTS Research & Development Jun 06, 2024
Principal RWE Research Analyst Hyderabad (Office) India Operations CTS Research & Development May 14, 2024
Principal Pharmacometrics Scientist London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 03, 2024
Principal Clinical Data Manager Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Sep 26, 2024
Principal Biostatistician Shanghai (Shanghai) China Development Innovative Medicines Research & Development Jun 20, 2024
Principal Biostatistician Home Worker United Kingdom Development Innovative Medicines Research & Development Sep 17, 2024
Principal /Senior Principal Scientist PKS Oncology Cambridge (USA) USA Biomedical Research Pharma Research Research & Development May 20, 2024
Pipeline Medical Manager CRM London (The Westworks) United Kingdom International Innovative Medicines Research & Development Oct 11, 2024
Patient Safety Specialist İstanbul Kavacık Turkey Development Innovative Medicines Research & Development Jun 10, 2024
Patient Safety Specialist Amiria Egypt Development Innovative Medicines Research & Development Aug 26, 2024
Patient Safety Manager Paris Headquarter (Novartis Pharma S.A.S.) France Development Innovative Medicines Research & Development Sep 04, 2024
Patient Safety Head US East Hanover USA Development Innovative Medicines Research & Development Jun 28, 2024
Patient Journey Partner Lead GTx INSURGENTES Mexico International Innovative Medicines Research & Development Oct 21, 2024
Patient Advocacy Manager Prague Czech Republic International Innovative Medicines Research & Development Oct 10, 2024
Patient Advocacy & Medical Lead Prague Czech Republic International Innovative Medicines Research & Development Oct 10, 2024
Oncology MSL INSURGENTES Mexico International Innovative Medicines Research & Development Oct 18, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia